We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Dolomite Bio Introduces New Single Nucleus RNA-Seq Chip for DroNc-Seq

Dolomite Bio Introduces New Single Nucleus RNA-Seq Chip for DroNc-Seq content piece image
Read time: Less than a minute

Dolomite Bio is pleased to announce the launch of a new chip for DroNc-Seq, enabling high throughput single nucleus RNA-Seq using droplet microfluidics. The single nucleus RNA-Seq chip – based on the company’s established scRNA-Seq chip – is designed to produce smaller droplets, allowing straightforward, low cost profiling of thousands of nuclei.

DroNc-Seq is a novel single cell RNA-Seq methodology which uses isolated nuclei instead of whole cells. Nuclei can be quickly and easily isolated from frozen or lightly fixed tissues – including tissues which are difficult to isolate individual cells from. This avoids lengthy and stressful manipulation of live cells, which could perturb expression profiles. Remarkably, the transcriptomes acquired are very similar to those from whole cells, albeit with a lower total transcript capture rate and greater representation of nuclear RNA and pre-mRNA.


The single nucleus RNA-Seq chip – compatible with Dolomite Bio’s Single Cell RNA-Seq System – is ideal for nuclei encapsulation, and has been optimized for the generation of smaller diameter droplets than those used in standard scRNA-Seq protocols. The single nucleus RNA-Seq chip for DroNc-Seq is available now. For more information or to order, visit www.dolomite-bio.com/how-it-works/single-nucleus-rna-seq/   


Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.